Joseph R. Shaw: Risk Stratification is Only Useful if It is Practical, Consistent, and Easy to Apply at the Bedside
Joseph R. Shaw, Director of Research Program at Ottawa Department of Medicine, EHJ-CVP Associate Editor of European Heart Journal, shared on LinkedIn about a recent article he and his colleagues co-authored, published in JTH, adding:
“Risk stratification is only useful if it is practical, consistent, and easy to apply at the bedside.
In our ISTH SSC guidance document, we propose a revised 3-tier procedural bleed risk framework for anticoagulated patients undergoing planned procedures:
minimal, low/moderate, and high bleed risk.
The goal is to support more consistent perioperative anticoagulation decisions across specialties, while recognizing that the classification is a starting point – not a substitute for clinical judgment.
Patient factors, procedural nuance, local resources, and multidisciplinary input still matter.
I hope this framework helps clinicians, proceduralists, and perioperative teams speak the same language when planning anticoagulant interruption and resumption.
Thanks to Thrombosis Canada and CLOT Conversations for highlighting this work.”
Title: Surgical and procedural bleed risk stratification for anticoagulated patients undergoing planned surgery: guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis
Authors: Joseph R. Shaw, Jameel Abdulrehman, Steffan Frosi Stella, Grigorios I. Leontiadis, Jan Steffel, Maria P. Ntalouka, Guillaume Martel, Kari A.O. Tikkinen10, Prism Schneider, Mark Turrentine, Achilleas Thoma, Daniel Lee, Adam P.J.J. Bray, Nick Blanas, Edsel Ing, Risa Shorr, Deborah M. Siegal, Jerrold H. Levy, Jean M. Connors, Alex C. Spyropoulos, James Douketis
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy